UT Southwestern Medical Center researchers have identified an experimental molecular compound that improved survival among cellular models and mouse models of amyotrophic lateral sclerosis (ALS), the fatal neurodegenerative disease. Their findings, reported in Cell Death & Disease, offer promise for the potential development of treatments for ALS, which has no effective therapy.
